Scientific letters

• Ivabradine for the prevention of sinus tachycardia-triggered ventricular fibrillation in hypertrophic cardiomyopathy

  Eva Cabrera-Borrego, Isabel Navarro-Pelayo Torres, Francisco Bermúdez-Jiménez, Francesca Perin, Rosa Macías-Ruiz, Juan Jiménez-Jáimez

  Rev Esp Cardiol. 2026;79:489-91

• Key messages on subclinical atrial fibrillation from the ARTESiA and NOAH trials

  Juan Benezet-Mazuecos, Jeff S. Healey

  Rev Esp Cardiol. 2026;79:280-2

• Commissural alignment with the Allegra transcatheter aortic bioprosthesis

  Jorge Sanz Sánchez, José Antonio Sorolla Romero, Jean Paul Vílchez Tschischke, Carles Fonfria, Ignacio J. Amat Santos, José Luis Díez Gil

  Rev Esp Cardiol. 2026;79:278-80

• Intravascular ultrasound to assess adverse pulmonary vascular remodeling in Fontan circulation

  Yassin Belahnech, Gerard Martí-Aguasca, Enric Domingo-Ribas, Eduard Ródenas-Alesina, Antonia Pijuan-Domenech, Laura Dos-Subirà

  Rev Esp Cardiol. 2026;79:275-8

• Microaxial flow pump malrotation and cardiogenic shock outcomes

  Sebastián Aranda-Martínez, Jorge Martínez-Solano, Antonio Portolés-Hernández, Iago Sousa-Casasnovas, Jorge García-Carreño, Manuel Martínez-Sellés

  Rev Esp Cardiol. 2026;79:270-2

• Insights into the optimal blanking period after pulmonary vein isolation with radiofrequency or pulsed-field ablation

  Josep Navarro-Manchón, María Teresa Izquierdo de Francisco, Óscar Cano Pérez, Francisco Javier Chorro Gascó, Luis Martínez-Dolz, Joaquín Osca Asensi

  Rev Esp Cardiol. 2026;79:387-9

• Perceptions of the Spanish population regarding various public health measures to control tobacco use

  Julia Rey-Brandariz, Carla Guerra-Tort, Ana Teijeiro, Lucía Rodríguez-Loureiro, Mónica Pérez-Ríos

  Rev Esp Cardiol. 2026;79:384-7

• Fontan completion in adulthood in patients with a functional single ventricle

  Tianyu Chen, Jianzheng Cen, Shusheng Wen, Jimei Chen, Xiaobing Liu, Jian Zhuang

  Rev Esp Cardiol. 2026;79:382-4

• Analysis of cardiomyopathy-associated genes in septic cardiomyopathy

  Filipe A. Gonzalez, Jacobo Bacariza, João Leote, Ana Rita Varudo, Ana G. Almeida, Luís R. Lopes

  Rev Esp Cardiol. 2026;79:379-82

• Mediterranean lifestyle for secondary prevention of cardiovascular disease: the MEDLIFE pilot study

  Jesús Díaz-Gutiérrez, María del Carmen Aznar de la Riera, Ana Blanca Paloma Martínez-Pérez, Emilio Amigo-Otero, Fernando Rodríguez-Artalejo, Mercedes Sotos-Prieto, on behalf of the MEDLIFE pilot study investigatorsAntonio Gómez-Menchero, Ana López Suárez, Raúl López Aguilar, María Luisa Hidalgo, Ana Rodríguez Morales

  Rev Esp Cardiol. 2026;79:377-9

• Long-term impact of an intensive telemedicine-based strategy for lipid management

  César Jiménez-Méndez, Rafael Vázquez-García, William Delgado, Daniel Bartolome, Etel Silva

  Rev Esp Cardiol. 2026;79:273-5

• Transfemoral recanalization of atretic aortic arch using radiofrequency wire

  Stefano Svab, Alain Fraisse, Konstantinos Dimopoulos, Isma Rafiq, Harith Alam, Alexander Kempny

  Rev Esp Cardiol. 2026;79:173-5

• ESSOS single breath-hold 3D magnetic resonance for the assessment of aortic dilation

  Sandra Gómez-Talavera, Álvaro Navarro-Guzmán, Rodrigo Fernández-Jiménez, Valentín Fuster, Javier Sánchez-González, Borja Ibáñez

  Rev Esp Cardiol. 2026;79:175-8

• Systematic triplet expansion testing in patients with genetically negative Brugada syndrome

  Alexis Hermida, Guillaume Jedraszak, Flavie Ader, Philippe Maury, Philippe Charron, Estelle Gandjbakhch

  Rev Esp Cardiol. 2026;79:178-80

• Rapid recurrences of coronary unexplained in-stent restenosis (RECUR): a novel pathologically-evidenced coronary inflammatory disease

  Zhangyu Lin, Xuejing Duan, Yuetang Wang, Qian Wang, Lei Jia, Kefei Dou

  Rev Esp Cardiol. 2026;79:180-4

• TTN cardiomyopathy: expanding clinical relevance beyond the A-band

  María Valverde-Gómez, Luis De La Higuera-Romero, Marlene Pérez-Barbeito, Soledad García-Hernández, Ivonne Cárdenas-Reyes, Juan Pablo Ochoa

  Rev Esp Cardiol. 2026;79:184-6

• Association between DNA methylation at smoking-related loci and mortality in patients with peripheral arterial disease

  Lidia Marcos-García, Albert Clarà, Sonia Pérez-Cabezón, Manuel Miralles-Hernández, Roberto Elosua, Alina Velescu

  Rev Esp Cardiol. 2026;79:80-2

• Small left ventricular end-diastolic dimensions identify patients with heart failure with supranormal left ventricular ejection fraction

  Enrique Santas, Rafael de la Espriella, Gema Miñana, Anna Mollar, Patricia Palau, Julio Núñez

  Rev Esp Cardiol. 2026;79:82-5

• Echocardiographic-fluoroscopic fusion imaging with the mini 3D transesophageal probe in pediatric congenital heart disease

  Ramona Ghenghea, Khaled Hadeed, Paul Vignaud-Marighetto, Nicolas Combes, Philippe Acar, Clement Karsenty

  Rev Esp Cardiol. 2026;79:85-8

• Feature tracking cardiovascular magnetic resonance to predict major adverse cardiovascular events in patients with cardiac amyloidosis

  Ilaria Dentamaro, Andrea Igoren Guaricci, Yassin Belahnech, Paolo Basile, Gianluca Pontone, José Fernando Rodríguez Palomares

  Rev Esp Cardiol. 2026;79:88-92